project id: TCGA-KIRP; case submitter id: TCGA-UZ-A9Q1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.98; rna integrity number: 9.3; age at index: 88; days to birth: -32142; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; age at diagnosis: 32142; ajcc clinical m: M0; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage I; ajcc pathologic t: T1b; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 730.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-UZ-A9Q1-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;